Back
Edge
StocktwitsEarnings
Official STOCKTWITS Representative

symbol logo$ABBV Q3 '26 Earnings Results & Recap

• Reported GAAP EPS of $3.82 up 105.38% YoY • Reported revenue of $17.4B up 10.32% YoY • AbbVie raised 2026 adjusted diluted EPS guidance from $13.76 - $13.96 to $13.95 - $13.99, including an unfavorable $0.69 per share impact related to acquired IPR&D and milestones expense incurred year-to-date through Q3 2026.

Price since post

Full Details

Advertisement|Remove ads.